Trial Search Results

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors . Images produced by PET/CT may provide better information about the distribution of particles, such as Y90 glass microspheres, delivered for selective internal radiation therapy (SIRT) as compared to regular medical care images useing technetium Tc-99m albumin-aggregated single photon emission computed tomography (SPECT)/CT images.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: Computed Tomography (CT)
  • Procedure: Positron Emission Tomography (PET)
  • Device: 90-Yttrium (Y-90) Glass Microspheres
  • Diagnostic Test: Technetium 99mTc albumin aggregated (99mTc-MAA)
  • Procedure: Single-photon emission computerized tomography (SPECT) scan

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Patient provides written informed consent

   - Patient is referred for 90Y SIRT radioembolization of liver tumor(s)

   - Patient is capable of complying with study procedures

   - Patient is able to remain still for duration of imaging procedure (approximately 30
   minutes total for digital PET/CT)

Exclusion Criteria:

   - Patient is pregnant or nursing

Ages Eligible for Study

18 Years - N/A

Genders Eligible for Study

All

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Risa Jiron
650-736-1598